Streetbeat News

Price Targets

RICK

HC Wainwright & Co. analyst Scott Buck has reiterated a Buy rating on RCI Hospitality Holdings (NASDAQ:RICK) with a maintained price target of $115.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:13 am

BITF

HC Wainwright & Co. analyst Kevin Dede has reaffirmed a Buy rating on Bitfarms (NASDAQ:BITF) and increased the price target from $3 to $4.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:10 am

CAN

HC Wainwright & Co. analyst Kevin Dede has maintained a Buy rating on Canaan (NASDAQ:CAN) but has reduced the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:08 am

WDAY

Needham analyst Scott Berg has reaffirmed a Buy rating on Workday (NASDAQ:WDAY) and increased the price target from $250 to $300.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:06 am

KRRO

RBC Capital analyst Luca Issi has initiated coverage on Korro Bio (NASDAQ:KRRO) with an Outperform rating and set a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:03 am

BTCUSD

Katie Stockton of Fairlead Strategies predicts a bullish trend for Bitcoin (BTC), expecting it to potentially reach $42,200 by the end of 2023. Bitcoin has already shown significant growth in 2023, with a 132% increase year to date. The cryptocurrency recently surpassed $38,000, a level not seen since May 2022. Stockton's confidence is supported by medium-term bullish technical indicators. Bitcoin's initial support is at its rising 50-day moving average of around $33,900. Standard Chartered also suggests Bitcoin could double to $100,000 in 2024.

Portfolio Pulse from Benzinga Neuro

November 29, 2023 | 11:00 am

SOPH

RBC Capital analyst Conor McNamara has initiated coverage on Sophia Genetics with an Outperform rating and set a price target of $8. The company is listed on NASDAQ under the ticker SOPH.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:53 am

AUTL

Needham analyst Gil Blum has reiterated a Buy rating on Autolus Therapeutics (NASDAQ:AUTL) and maintained a $7 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:50 am

INTU

Barclays analyst Raimo Lenschow has maintained an Overweight rating on Intuit (NASDAQ:INTU) and increased the price target from $570 to $660.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:43 am

HPE

Barclays analyst Tim Long has maintained an Equal-Weight rating on Hewlett Packard (NYSE:HPE) but has reduced the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:40 am